Spots Global Cancer Trial Database for Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
Official Title:
Study ID: NCT00054873
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
ACRC/Arizona Clinical Research Center, Tucson, Arizona, United States
Glendale Memorial Hospital, Glendale, California, United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Tower Hematology Oncology Medical Group, Los Angeles, California, United States
Comprehensive Cancer Center at DRMC, Palm Springs, California, United States
Desert Regional Medical Center, Palm Springs, California, United States
Sharp Clinical Oncology Research, San Diego, California, United States
UCSF Comprehensive Cancer Center, San Francisco, California, United States
Cancer Institute Medical Group, Santa Monica, California, United States
Denver VAMC, Denver, Colorado, United States
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Memorial Regional Comprehensive Cancer Center, Weston, Florida, United States
Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, Illinois, United States
The University of Chicago, Chicago, Illinois, United States
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
LSU Health Sciences Center, Dept. of Medicine, Hematology/Oncology, Shreveport, Louisiana, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
University of Michigan Medical Center, Ann Arbor, Michigan, United States
Josephine Ford Cancer Center, Henry Ford Health System, Detroit, Michigan, United States
Kansas City Oncology and Hematology Group, Kansas City, Missouri, United States
Washington University School of Medicine, St. Louis, Missouri, United States
Duke University Medical Center, Durham, North Carolina, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
The Sarah Cannon Cancer Center, Tennessee Oncology, Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
Swedish Cancer Institute, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
